A director at Crescent NV bought 23,809,524 shares at 0.010EUR and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Aedifica: Capex continues the diversification Besi: Better Q1 results | Q2 outlook disappoints Brunel International: Strong start to the year; exiting Russia Corbion: Solid 1Q top line, better than expected EBITDA Crescent: Remoticom integration should trigger sales growth Euronav: Swapping non-ECO for ECO VLCCs EXMAR: Q1 Trading Update Intertrust: Staff attrition weighs on results; CSC deal progressing Materialise: Performing well Proximus: Slightly better Q1 | FY22 outlook reiterated Qrf: Achi...
Argenx: Capital raise increased to $ 805m BESI: Convertible debt issuance of € 175m Crescent: Now 1,994,069,719 shares + new financing Kinepolis: CFO De Clercq leaving, big shoes to fill PostNL: Director of PNL Belgium arrested Roularta: Becoming owner of largest Belgian health websites Sipef: Change in export levy Telecom: Newcomer exercises option for reserved spectrum
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.